Doctor profile · Federal record
Dr. Fethi Benraouane, MD
Cardiovascular Disease Physician (CMS: Cardiovascular Disease (Cardiology)) · Interventional Cardiology Physician · Internal Medicine Physician · Webster, TX
- NPI 1720243736
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 28 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 9 locations across 1 states.
- Primary practice
-
905 W Medical Center Blvd Ste 103
Webster, TX 775984009
(281) 724-4711
fax (832) 632-1417 - Mailing address
-
Po Box 58538
Webster, TX 775988538
Texas — 8 locations
- Additional location
-
4615 Southwest Fwy Ste 900
Houston, TX 770277191
(346) 209-3003 - Additional location
-
500 N Kobayashi Ste A
Webster, TX 775984722
(281) 724-7341 - Additional location
-
500 N Kobayashi Ste C
Webster, TX 775984722
(281) 816-3092 - Additional location
-
5010 Crenshaw RD Ste 130
Pasadena, TX 775054615
(832) 743-6922
fax (832) 761-9738 - Additional location
-
530 Orchard St
Webster, TX 775984110
(281) 338-4004 - Additional location
-
600 N Kobayashi Ste 110
Webster, TX 775984841
(281) 338-1701 - Additional location
-
600 N Kobayashi Ste 309
Webster, TX 775984841
(281) 724-8332 - Additional location
-
905 W Medical Center Blvd Ste 102
Webster, TX 775984009
(346) 688-0043
fax (346) 610-9002
Credentials & registration
- NPI registered
- July 2008 — 18 yrs on file
- Profile last updated
- March 17, 2026
- Year of graduation
- 1998 — 28 yrs since
- Specialty taxonomy
- 207RC0000X — NUCC code
- State license (1)
- Texas #P8117
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1720243736. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
4,277
Distinct HCPCS
10
Medicare allowed
$667,175
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 851 | 189 | $118 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 810 | 398 | $126 | |
93000 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 422 | 310 | $14 | |
J2785 |
Injection, regadenoson, 0.1 mg | 308 | 77 | $54 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 234 | 202 | $174 | |
93306 |
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 215 | 208 | $177 | |
93306 |
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 202 | 195 | $66 | |
A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose | 130 | 107 | $155 | |
93970 |
Ultrasound study of arm or leg veins with compression and maneuvers | 120 | 100 | $183 | |
93015 |
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 110 | 110 | $62 |
In context: peer comparison
Among 9 peers in this city , average services per provider: 158. This provider delivers 27× the peer median.Open Payments
Industry payments received
All-time total
$2,662
Transactions
80
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Medtronic, Inc. | 9 | $492.11 | |
| Boston Scientific Corporation | 12 | $467.20 | |
| Novartis Pharmaceuticals Corporation | 12 | $259.07 | |
| Edwards Lifesciences Corporation | 3 | $234.96 | |
| Abbott Laboratories | 7 | $181.86 | |
| Amgen Inc. | 10 | $160.77 | |
| Actelion Pharmaceuticals US, Inc. | 6 | $141.20 | |
| Lexicon Pharmaceuticals, Inc. | 2 | $119.02 | |
| ABIOMED | 1 | $93.16 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $87.67 | |
| Janssen Pharmaceuticals, Inc | 4 | $57.73 | |
| Tactile Systems Technology Inc | 3 | $53.64 | |
| Inari Medical, Inc. | 3 | $49.71 | |
| AngioDynamics, Inc. | 1 | $48.56 | |
| Novo Nordisk Inc | 2 | $47.72 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
4,841
Patients
1,772
Total drug cost
$1,223,000
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Metoprolol Succinate | Generic | 531 | 191 | $10,030 |
| Eliquis (Apixaban) | Brand | 507 | 143 | $522,776 |
| Furosemide | Generic | 471 | 185 | $3,412 |
| Rosuvastatin Calcium | Generic | 390 | 160 | $13,318 |
| Atorvastatin Calcium | Generic | 367 | 138 | $5,049 |
| Spironolactone | Generic | 362 | 133 | $5,530 |
| Metoprolol Tartrate | Generic | 332 | 127 | $2,954 |
| Valsartan | Generic | 328 | 114 | $16,012 |
| Amlodipine Besylate | Generic | 275 | 108 | $2,789 |
| Entresto (Sacubitril/Valsartan) | Brand | 257 | 81 | $356,029 |
Hospital affiliations
Frequently asked questions
What is Dr. Fethi Benraouane's medical specialty?
Dr. Fethi Benraouane practices Cardiovascular Disease Physician in Webster, TX.
Where does Dr. Fethi Benraouane practice?
Dr. Fethi Benraouane practices at 905 W Medical Center Blvd Ste 103, Webster, TX 775984009. Office phone: 2817244711.
What is Dr. Fethi Benraouane's NPI?
Dr. Fethi Benraouane's National Provider Identifier (NPI) is 1720243736, issued by NPPES.
Does Dr. Fethi Benraouane accept Medicare assignment?
Yes. Dr. Fethi Benraouane accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Fethi Benraouane commonly perform?
Top Medicare-reported procedures in 2023: Subsequent hospital care with moderate levelof medical decision making (HCPCS 99233); Established patient office or other outpatient visit (HCPCS 99214); Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS 93000). Source: CMS Medicare Physician & Other Practitioners file.